Sofie Biosciences acquired by GE HealthCare
GE HealthCare agreed to acquire Sofie Biosciences, a US radiopharmaceutical manufacturing brand.
Transaction summary
- Target
- Sofie Biosciences
- Acquirer
- GE HealthCare
- Seller
- -
- Announced
- -
- Geography
- United States
- Tags
- Contract manufacturingDiagnosticsHealthcareMedtechradiopharmaceutical manufacturingradiopharmaceuticals
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-10-07
- Latest update
- 2026-10-11
Value and multiples
100% enterprise value
USD 945M
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 945M
MedTech Dive reported a $945 million cash acquisition; the specific percentage acquired is not stated.
Basis
- Reported enterprise value: USD 945m.
Source summary
GE HealthCare to acquire Sofie Biosciences for $945M
ConfirmedMedTech Dive reported on October 5, 2026 that GE HealthCare agreed to acquire Sofie Biosciences for $945 million in cash, with closing expected in the first half of 2027. The article describes Sofie’s U.S. PET radiopharmaceutical manufacturing and distribution business; it gives no revenue or EBITDA figures.
Open sourceGE HealthCare to acquire Sofie Biosciences for $945M
ConfirmedMedTech Dive reported on October 5, 2026 that GE HealthCare agreed to acquire Sofie Biosciences for $945 million in cash, with closing expected in the first half of 2027. The article describes Sofie’s U.S. PET radiopharmaceutical manufacturing and distribution business; it gives no revenue or EBITDA figures.
Open sourceContinue your research
Related transaction comps
Avanos Medical, Inc. acquired by American Industrial Partners
2026-07-27 · Confirmed
View transaction → Contract manufacturingBentley Laboratories acquired by THG
2021-05-11 · Estimated
View transaction → radiopharmaceuticalsITM Isotope Technologies Munich SE acquired by Telix Pharmaceuticals Limited
- · Confirmed
View transaction → HealthcareBIO-CAT Enzymes & Microbials acquired by Lallemand Inc.
2026-07-31 · Confirmed
View transaction →